SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 44 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $5,066 | -15.3% | 3,005,000 | -3.0% | 0.02% | -22.7% |
Q1 2023 | $5,983 | -31.5% | 3,097,000 | -33.7% | 0.02% | -29.0% |
Q4 2022 | $8,731 | -100.0% | 4,674,000 | -80.0% | 0.03% | -78.3% |
Q3 2022 | $39,095,000 | +491.5% | 23,424,000 | +344.7% | 0.14% | +521.7% |
Q2 2022 | $6,610,000 | -8.1% | 5,267,000 | -3.8% | 0.02% | +21.1% |
Q1 2022 | $7,194,000 | -89.9% | 5,476,000 | -88.7% | 0.02% | -88.3% |
Q4 2021 | $71,054,000 | +228.1% | 48,435,000 | +449.0% | 0.16% | +184.2% |
Q4 2020 | $21,654,000 | +19.2% | 8,823,000 | +0.8% | 0.06% | -1.7% |
Q3 2020 | $18,167,000 | -51.1% | 8,751,000 | -45.9% | 0.06% | -55.4% |
Q2 2020 | $37,158,000 | +346.7% | 16,173,000 | +195.3% | 0.13% | +251.4% |
Q1 2020 | $8,319,000 | +29.1% | 5,477,000 | +12.5% | 0.04% | +68.2% |
Q3 2019 | $6,446,000 | -65.2% | 4,870,000 | -41.4% | 0.02% | -63.3% |
Q2 2019 | $18,534,000 | +17.4% | 8,317,000 | -4.6% | 0.06% | +13.2% |
Q1 2019 | $15,787,000 | – | 8,719,000 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DeepCurrents Investment Group LLC | 92,999,000 | $138,298,000 | 4.13% |
WOLVERINE ASSET MANAGEMENT LLC | 84,505,000 | $125,210,000 | 1.08% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 20,000,000 | $29,789,000 | 0.79% |
Verition Fund Management LLC | 27,047,000 | $40,063,000 | 0.35% |
ADVENT CAPITAL MANAGEMENT /DE/ | 7,970,000 | $11,789,000 | 0.22% |
Baker Brothers Advisors | 29,174,000 | $43,167,000 | 0.19% |
Calamos Advisors LLC | 23,631,000 | $35,035,000 | 0.15% |
RWC Asset Management LLP | 2,900,000 | $4,300,000 | 0.13% |
Aequim Alternative Investments LP | 1,957,000 | $2,899,000 | 0.11% |
PALISADE CAPITAL MANAGEMENT, LP | 3,148,000 | $4,666,000 | 0.10% |